Shaheen Patel1, Joyce J Mathan2, Ehsan Vaghefi2, Andrea J Braakhuis3. 1. Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland, M&HS Building 504, Level 2, Room 504-202, 85 Park Rd, Auckland, 1023, Grafton, New Zealand. 2. Department of Optometry and Vision Science, Faculty of Medical and Health Science, The University of Auckland, Auckland, New Zealand. 3. Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland, M&HS Building 504, Level 2, Room 504-202, 85 Park Rd, Auckland, 1023, Grafton, New Zealand. a.braakhuis@auckland.ac.nz.
Abstract
BACKGROUND: Glaucoma is a leading cause of irreversible blindness worldwide. A major symptom of this pathology is the loss to the visual field in a peripheral to central pattern. Flavonoids are polyphenol compounds sourced from plants, commonly found in green tea, red wine and cocoa, and they have neuroprotective and antioxidant characteristics proposed to be advantageous within the context of glaucoma. Currently, the literature presents conflicting evidence regarding the effect of flavonoids on patients with glaucoma and ocular hypertension; hence a systematic review and meta-analysis was conducted. METHOD: Databases included in our literature search were EMBASE (1980-present), MEDLINE Ovid, Alternative and Complementary Medicine Database (AMED), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Cochrane Central Register of Controlled Trials (CENTRAL). Meta-analysis was performed using RevMan 5 (Review Manager) 5 software, version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen). The primary outcomes were visual field mean deviation (MD) and intraocular pressure (IOP). Secondary outcomes were ocular blood flow and blood pressure (BP). CONCLUSION: Meta-analyses showed that flavonoids have a promising role in improving visual function in patients with glaucoma and ocular hypertension (OHT), and appear to play a part in both improving and slowing the progression of visual field loss.
BACKGROUND:Glaucoma is a leading cause of irreversible blindness worldwide. A major symptom of this pathology is the loss to the visual field in a peripheral to central pattern. Flavonoids are polyphenol compounds sourced from plants, commonly found in green tea, red wine and cocoa, and they have neuroprotective and antioxidant characteristics proposed to be advantageous within the context of glaucoma. Currently, the literature presents conflicting evidence regarding the effect of flavonoids on patients with glaucoma and ocular hypertension; hence a systematic review and meta-analysis was conducted. METHOD: Databases included in our literature search were EMBASE (1980-present), MEDLINE Ovid, Alternative and Complementary Medicine Database (AMED), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Cochrane Central Register of Controlled Trials (CENTRAL). Meta-analysis was performed using RevMan 5 (Review Manager) 5 software, version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen). The primary outcomes were visual field mean deviation (MD) and intraocular pressure (IOP). Secondary outcomes were ocular blood flow and blood pressure (BP). CONCLUSION: Meta-analyses showed that flavonoids have a promising role in improving visual function in patients with glaucoma and ocular hypertension (OHT), and appear to play a part in both improving and slowing the progression of visual field loss.
Entities:
Keywords:
Blood flow; Glaucoma; Intraocular pressure; Polyphenol; Visual field
Authors: Nicholas K H Khoo; C Roger White; Lucas Pozzo-Miller; Fen Zhou; Chad Constance; Takafumi Inoue; Rakesh P Patel; Dale A Parks Journal: Free Radic Biol Med Date: 2010-04-25 Impact factor: 7.376
Authors: Andra Morrison; Julie Polisena; Don Husereau; Kristen Moulton; Michelle Clark; Michelle Fiander; Monika Mierzwinski-Urban; Tammy Clifford; Brian Hutton; Danielle Rabb Journal: Int J Technol Assess Health Care Date: 2012-04 Impact factor: 2.188
Authors: Jae H Kang; Kerry L Ivey; Tahani Boumenna; Bernard Rosner; Janey L Wiggs; Louis R Pasquale Journal: Acta Ophthalmol Date: 2018-03-14 Impact factor: 3.761
Authors: James R Tribble; Flora Hui; Melissa Jöe; Katharina Bell; Vicki Chrysostomou; Jonathan G Crowston; Pete A Williams Journal: Cells Date: 2021-02-01 Impact factor: 6.600